Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the ...
About us. Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope ...
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ...
Exelixis
Chaîne de biotechnologie
Exelixis, Inc. est une société de découverte de médicaments basée sur la génomique située à Alameda, en Californie, et le producteur de Cometriq, un traitement approuvé par la Food and Drug Administration des ... Wikipédia (anglais)
PDG : Michael M. Morrissey (juil. 2010–)
Président : Michael M. Morrissey
Revenus : 1,435 milliard USD (2021)
Fondateurs : Corey Goodman et Stelios Papadopoulos
Création : 15 novembre 1994, Cambridge, Massachusetts
Siège social : Alameda, Californie
Mnémo : Nasdaq
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the ...
Biotechnology company striving to accelerate the development of new medicines for difficult-to-treat cancers. See our guidelines: https://t.co/eaLlId7wLk.
8 janv. 2024 · The stream of new year layoffs shows no sign of abating, with Exelixis announcing that around 175 of its staff will heading for the exits.
Learn about Exelixis Medical Affairs and how we improve patient outcomes in our clinical trials through innovation, communication, and research.